āagman

Alivus Life Sciences Ltd

NSE: ALIVUS
₹1,257.90
−₹10.70 (−0.84%)
NSE · 21 Oct 2026, close
NSE
As of 31 Mar 2021
Market Cap
₹16,766 Cr
CMP
₹1,257.90
52-wk High / Low
₹1,494 / 819
P/E
47.7
Div Yield
0.37%
Face Value
₹2

Price+34.6% over 1Y

āagman read

Computed by āagman
Derived from 3 years and 0 quarters of filings. Not reported by the company.
As of 21 Oct 2026
How we compute these
Piotroski F-Score
3
/ 9
3 of 9 F-score tests passed
Holder deltas
QoQ
pp
Prom +0.00FII +0.24DII −0.09
Latest quarter vs the previous one
Strengths
+Price trades above its 200-day moving average (1.1x)
+FII holding rose by 2.3pp over the last year
Watch-outs
−Promoter holding fell by 8.0pp over the last year
−Piotroski F-Score of 3/9 is in the weak band (≤3)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated · ₹ Cr

Profit & Loss

As of 31 Mar 2021
Consolidated · ₹ Cr · 3 years
Mar 2019Mar 2020Mar 2021
Sales8861,5371,885
Expenses6391,0651,294
Operating Profit248472591
OPM %28.0%30.7%31.4%
Other Income0121
Interest13488
Depreciation192933
Profit before tax228421471
Net Profit196313352
EPS (₹)997.861,597.37358.74

Balance Sheet

Consolidated · ₹ Cr

Cash Flows

As of 31 Mar 2021
Consolidated · ₹ Cr
Mar 2019Mar 2020Mar 2021
Cash from Operating Activity———
Cash from Investing Activity———
Cash from Financing Activity———
Net Cash Flow———

Ratios

As of 31 Mar 2021
3 periods
Mar 2019Mar 2020Mar 2021
ROCE %———
ROE %———
EPS (₹)997.861,597.37358.74
Book Value (₹)———
Face Value (₹)——2
P/E——47.7
Div Yield %——0.37
NPM %22.120.218.7
OPM %28.031.031.0
D/E———
P/B———

Growth

As of 27 Sep 2026
Compounded sales growth
TTM+23.0%
Compounded profit growth
TTM+12.0%
Stock price CAGR
5 years+15.0%
3 years+30.0%
Last year+45.0%

Shareholding pattern

As of 31 Dec 2024
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters82.85%82.85%82.85%82.85%74.99%74.87%74.87%
FIIs8.12%8.12%3.28%5.01%6.57%5.30%5.54%
DIIs0.56%0.56%0.00%1.41%5.19%7.27%7.18%
Government———————
Public8.47%8.47%13.86%10.73%13.25%12.55%12.42%
No. of shareholders2,38,5782,38,5782,22,8661,56,1831,41,9771,27,9691,25,559
Change since Jun 2023 (pp)
Promoters −7.98FIIs −2.58DIIs +6.62Public +3.95

Documents

As of 27 Sep 2026
Announcements
The Company Has Incorporated A Wholly Owned Subsidiary Company In Brazil.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationShareholder Meeting / Postal Ballot-Scrutinizer''s ReportShareholder Meeting / Postal Ballot-Outcome of AGMAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingJan 2026TranscriptJan 2026PPTJan 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025RecordingAug 2025TranscriptAug 2025PPT

Corporate actions

As of 1 Sep 2026
1 Sep 2026DIVIDENDDividend - Rs 5 Per Share—
1 Sep 2025DIVIDENDDividend - Rs 5 Per Share—
17 Oct 2023DIVIDENDInterim Dividend - Rs 22.50 Per Share—
24 Mar 2023DIVIDENDInterim Dividend - Rs 21 Per Share—
15 Sep 2022DIVIDENDDividend - Rs 10.5 Per Share—
22 Nov 2021DIVIDEND Interim Dividend - Rs 10.50 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges.© 2026 āagman